Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new Cochrane review has …
Artikel ini bersumber dari Cochrane.org pada April 16, 2026 at 5:00 AM.
To view and participate in discussions about this article, please visit the original source.
View Original Article